内蒙古家族性扩张型心肌病家系致病基因筛查
该研究对内蒙古一个家族性扩张型心肌病(DCM)家系中3例患者及20名成员进行病史、心电图、超声心动图检查,并采用芯片捕获测序检测遗传性心肌病及心律失常相关基因,Sanger测序验证疑似致病位点,另设150名健康对照。结果在先证者及3名家庭成员中检出MYBPC3、DSP、DMD基因的5个变异,家系其他成员及对照均未检出。结论提示这些基因变异可能与家族性DCM发病相关。
要点
- 家族性DCM家系中检出MYBPC3、DSP、DMD基因变异。
- 先证者携带5个基因变异,包括MYBPC3两个、DSP一个、DMD两个。
- 3例患者及1例未发病成员检出有害变异,对照未检出。
核心结论
- 该家族性DCM家系中存在MYBPC3、DSP、DMD基因变异,可能与家族性DCM发病相关。
研究设计与样本
- 研究纳入2003年10月至2017年8月内蒙古鄂尔多斯市中心医院同一家系的DCM患者3例及家系成员20名。
- 采用芯片捕获测序检测遗传性心肌病及遗传性心律失常相关基因外显子及剪切位点,疑似致病位点经Sanger测序验证。
- 另选取性别、年龄、种族匹配的健康人150名作为对照。
主要发现
- 先证者(Ⅱ1)检出5个基因变异:MYBPC3基因p.Ser236Gly和p.Arg215Cys、DSP基因p.Gln90Arg、DMD基因p.Asn2912Asp和p.Glu2910Val。
- Ⅲ3检出MYBPC3基因p.Arg215Cys变异1个。
- Ⅲ7检出MYBPC3基因p.Ser236Gly和DSP基因p.Gln90Arg变异2个。
- Ⅳ7检出MYBPC3基因p.Ser236Gly和DSP基因p.Gln90Arg变异2个。
- 其余家系成员及150名健康对照均未检出上述基因变异位点。
临床怎么用
- 对家族性DCM家系可考虑对遗传性心肌病相关基因进行芯片捕获测序筛查。
- 检出MYBPC3、DSP、DMD基因变异可能有助于家系成员的遗传风险评估。
局限性
- 原文未报告变异的功能验证及家系外人群的验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: Screen the pathogenic genes of a pedigree with clinical manifestation of familial dilated cardiomyopathy in Inner Mongolia. Methods: A total of 3 patients with dilated cardiomyopathy and 20 family members from the same family were examined in Ordos Central Hospital in Inner Mongolia from October, 2003 to August, 2017. Data on medical history, physical examinations, electrocardiograms, and echocardiography were obtained. 5 ml peripheral blood was sampled for per person. Chip Capture Sequencing technology was used to capture all the exons and splice sites of the genes that associated with hereditary cardiomyopathy and hereditary arrhythmia. The mutations in these genes were detected by high-throughput sequencing. All suspected pathogenic loci identified by high-throughput sequencing were verified by Sanger sequencing used for mutation detection. One hundred and fifty gender, age and race matched healthy people were included as the control group. Results: Pathogenic gene variations were detected in 3 symptomatic family members and 1 carrier from the pedigree. Five pathogenic gene variations were identified in the proband (Ⅱ1), a pSer236Gly and a pArg215Cys variation in the MYBPC3 gene, a pGln90Arg variation in the DSP gene, and pAsn2912Asp and pGlu2910Val variation in the DMD gene. One pathogenic variation was detected in Ⅲ3, which was a pArg215Cys variation in the MYBPC3 gene. Two pathogenic variations were detected in Ⅲ7, a pSer236Gly variation in the MYBPC3 gene and a pGln90Arg variation in the DSP gene. Two pathogenic variations were detected in the Ⅳ7, a pSer236Gly variation in the MYBPC3 gene and a pGln90Arg variation in the DSP gene. No gene variation loci were detected in the other family members and the control group. Conclusion: MYBPC3 gene, DSP gene and DMD gene variations are present in the familial dilated cardiomyopathy pedigree from Inner Mongolia, and these variations may be related with familial dilated cardiomyopathy. 目的: 通过对内蒙古自治区一家族性扩张型心肌病(DCM)家系进行致病基因筛查,探讨家族性DCM的致病基因突变位点。 方法: 入选2003年10月至2017年8月内蒙古鄂尔多斯市中心医院收治的同一家系的DCM患者3例及其家系成员20名。询问先证者及其家系成员的病史、家族史,并进行体格检查、常规心电图和超声心动图检查。同时每个家系成员抽取5 ml外周血,应用芯片捕获测序技术捕获遗传性心肌病及遗传性心律失常相关基因所有的外显子及剪切位点,通过高通量测序检测这些基因的突变情况,对高通量测序中出现的疑似致病位点,均通过突变检测的Sanger测序验证。另选取性别、年龄、种族与上述家系成员相匹配的健康人150名作为对照。 结果: 该家系中3例DCM患者和1例未发病者均检出相关的有害变异。先证者(女性)检出5个基因变异,分别为MYBPC3基因的p.Ser236Gly和p.Arg215Cys变异,DSP基因的p.Gln90Arg变异,DMD基因的p.Asn2912Asp和p.Glu2910Val变异。先证者二女儿检出1个基因变异,为MYBPC3基因的p.Arg215Cys变异。先证者三女儿检出2个基因变异,分别为MYBPC3基因的p.Ser236Gly变异和DSP基因的p.Gln90Arg变异。先证者外孙女检出2个基因变异,分别为MYBPC3基因的p.Ser236Gly变异和DSP基因的p.Gln90Arg变异。其余家系成员及健康对照人群均未检出上述基因变异位点。 结论: 该研究在内蒙古自治区一家族性DCM家系中发现MYBPC3、DSP、DMD基因的5个变异,而其可能与家族性DCM发病相关。.
引用
- Liu XP, Feng YB, Zeng Y, et al. [Screening of pathogenic genes in a Chinese familial dilated cardiomyopathy pedigree from Inner Mongolia]. Zhonghua Xin Xue Guan Bing Za Zhi. 2019. PMID: 30897878. doi:10.3760/cma.j.issn.0253-3758.2019.03.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。